• IP addresses are NOT logged in this forum so there's no point asking. Please note that this forum is full of homophobes, racists, lunatics, schizophrenics & absolute nut jobs with a smattering of geniuses, Chinese chauvinists, Moderate Muslims and last but not least a couple of "know-it-alls" constantly sprouting their dubious wisdom. If you believe that content generated by unsavory characters might cause you offense PLEASE LEAVE NOW! Sammyboy Admin and Staff are not responsible for your hurt feelings should you choose to read any of the content here.

    The OTHER forum is HERE so please stop asking.

Important: Please avoid administering Pfizer or Moderna on our kids, teens & NSFs

VIRUS%20VIXE3%20(7).jpg


VIRUS%20VIXE3%20(3).jpg
 
if there is a lot of deaths and hospitalizations in the next 10 years, will insurance company bankrupt and defaults those 20 years saving plans payout?
or will they denied all payouts?
 
if there is a lot of deaths and hospitalizations in the next 10 years, will insurance company bankrupt and defaults those 20 years saving plans payout?
or will they denied all payouts?
I never think so far. Is that why my NTUC INCOME is restructuring?

But it is true that many more people got brain stroke, heart issues, vascular clots in the past 2 years.
 
Pfizer's Report
https://drtrozzi.org/wp-content/upl...-Post-authorization-Adverse-Event-Reports.pdf

“Pregnancy outcomes for the 270 pregnancies were reported as spontaneous abortion (23), outcome pending (5), premature birth with neonatal death, spontaneous abortion with intrauterine death (2 each), spontaneous abortion with neonatal death, and normal outcome (1 each). No outcome was provided for 238 pregnancies (note that 2 different outcomes were reported for each twin, and both were counted).”

Simplified Version:
Of the 270 pregnancies, there were 23 spontaneous abortions, 5 “outcomes pending”, 2 premature birth with neonatal death, 2 spontaneous abortions with intrauterine death, 1 spontaneous abortion with neonatal death, and 1 normal outcome. But note also “no outcome was provided for 238 pregnancies”.

No information on 243 (5 + 238) of the pregnancies of these injected women; they have just not been included in the report. Next, of the 27 reported pregnancies (270 subtract 243), there are 28 dead babies! This appears to mean that someone was pregnant with twins and that 100% of the unborn babies died.
 
10,570 deaths and 405,259 injuries recorded in report from European Medicines Agency (EMA), an agency of the European Union (EU) in charge of the evaluation and supervision of medical products, using the data base EudraVigilance which collects reports of suspected side effects of medicines including vaccines

https://vaccineimpact.com/2021/1057...-adverse-drug-reactions-for-covid-19-vaccines


The Pfizer-BioNTech mRNA gene-edited vaccine resulted in the largest fatalities– 5,368 deaths and 170,528 injuries or nearly 50% of the total for all four.

The Moderna mRNA vaccine was second with 2,865 deaths and 22,985 injuries. That is to say, the only two gene manipulated mRNA experimental vaccines, Pfizer-BioNTech and Moderna, accounted for 8,233 deaths of the total registered deaths of 10,570. That’s 78% of all deaths from the four vaccines currently in use in the EU.

And among the serious side effects or injuries recorded by the EMA, for the two mRNA vaccines which we focus on in this article, for the Pfizer “experimental” vaccine, most reported injuries included blood and lymphatic system disorders including deaths; cardiac disorders including deaths; musculoskeletal and connective tissue disorders; respiratory, thoracic and mediastinal disorders, and vascular disorders.

For the Moderna mRNA vaccine, most serious injuries or causes of death included blood and lymphatic system disorders; cardiac disorders; musculoskeletal and connective tissue disorders; disorders of the central nervous system.
 
In a major new study just published in the International Journal of Vaccine Theory, Practice and Research, Dr. Stephanie Seneff, senior scientist at the MIT Computer Science and Artificial Intelligence Laboratory, and Dr. Greg Nigh, Naturopathic oncology specialist, analyze in detail the possible pathways in which the experimental mRNA vaccines of Pfizer and Moderna could be causing such adverse effects in the vaccinated. To keep the mRNA from breaking down before it could produce protein, mRNA vaccine makers substitute methyl-pseudouridine to stabilize RNA against degradation, allowing it to survive long enough to produce adequate amounts of protein antigen.

For various reasons to avoid using aluminum adjuvants to boost the antibody response, both mRNA vaccines use polyethylene glycol, or PEG, as adjuvant. This has consequences. The authors point out, “…both mRNA vaccines currently deployed against COVID-19 utilize lipid-based nanoparticles as delivery vehicles. The mRNA cargo is placed inside a shell composed of synthetic lipids and cholesterol, along with PEG to stabilize the mRNA molecule against degradation.”

PEG has been shown to produce anaphylactic shock or severe allergenic reactions. The second injection exposure is likely to cause even larger numbers of anaphylactic reactions.” One study noted, “PEG is a high-risk ‘hidden’ allergen, usually unsuspected, and can cause frequent allergic reactions due to inadvertent re-exposure.” Among such reactions are included life-threatening cardiovascular collapse.

Antibody-Dependent Enhancement (ADE) is an immunological phenomenon. The authors suggest that in the case of both Pfizer and Moderna mRNA vaccines, “non-neutralizing antibodies form immune complexes with viral antigens to provoke excessive secretion of pro-inflammatory cytokines, and, in the extreme case, a cytokine storm causing widespread local tissue damage.”

To be clear, normally cytokines are part of the body’s immune response to infection. But their sudden release in large quantities, a cytokine storm, can cause multi-system organ failure and death. Our innate immune system undergoes an uncontrolled and excessive release of pro-inflammatory signaling molecules called cytokines.

The authors also make numerous other alarming points including emergence of auto-immune diseases such as Celiac disease, a disease of the digestive system that damages the small intestine and interferes with the absorption of nutrients from food. Also Guillain-Barré syndrome (GBS) that causes progressive muscle weakness and paralysis. Additionally, Immune thrombocytopenia (ITP) in which a person has unusually low levels of platelets — the cells that help blood to clot– could occur following vaccination “through the migration of immune cells carrying a cargo of mRNA nanoparticles via the lymph system into the spleen… ITP appears initially as petechiae or purpura on the skin, and/or bleeding from mucosal surfaces. It has a high risk of fatality through haemorrhaging and stroke.”



https://ijvtpr.com/index.php/IJVTPR/article/view/23/51
 
In recent months, several NSFs collapsed and carried into SAF Medical Centers this year on stretchers, after third jab.

It is time for us to stop accusing "underlying conditions" and recognize the "underlying problems" and halt the senseless mRNA vaccination programme.

I challenge our God-damned policymakers to ask all SAF regulars to take the 4th mRNA jabs and see them drop like flies.


  1. McCullough PA, Alexander PE, Armstrong R, et al. Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19). Rev Cardiovasc Med (2020) 21:517–530. doi:10.31083/j.rcm.2020.04.264
  2. Arvin AM, Fink K, Schmid MA, et al. A perspective on potential antibody- dependent enhancement of SARS-CoV-2. Nature (2020) 484:353–363. doi:10.1038/s41586-020-2538-8
  3. Coish JM, MacNeil AJ. Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19. Microbes Infect (2020) 22(9):405-406. doi:10.1016/j.micinf.2020.06.006
  4. Eroshenko N, Gill T, Keaveney ML, et al. Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures. Nature Biotechnol (2020) 38:788–797. doi:10.1038/s41587-020-0577-1
  5. Poland GA. Tortoises, hares, and vaccines: A cautionary note for SARS-CoV-2 vaccine development. Vaccine (2020) 38:4219–4220. doi:10.1016/j.vaccine.2020.04.073
  6. Shibo J. Don’t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees. Nature (2000) 579,321. doi:10.1038/d41586-020-00751-9
  7. Munoz FA, Cramer JP, Dekker CL, et al. Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine (2021) https://doi.org/10.1016/j.vaccine.2021.01.055
  8. Cardozo T, Veazey R. Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease. Int J Clin Pract (2020) 28:e13795. doi: 10.1111/ijcp.13795
  9. Bolles D, Long K, Adnihothram S, et al. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge. J Virol (2001) 85:12201–12215. doi:10.1128/JVI.06048-11
  10. Weingartl H, Czub M, Czub S, et al. Immunization with modified vaccinia virus Ankarabased recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J Virol (2004) 78:12672–12676. doi:10.1128/JVI.78.22.12672-12676.2004272
  11. Tseng CT, Sbrana E, Iwata-Yoshikawa N, et al. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PLoS One (2012) 7(4):e35421. doi: 10.1371/journal.pone.0035421
  12. Iwasaki A, Yang Y. The potential danger of suboptimal antibody responses in COVID-19. Nat Rev Immunol (2020) 20:339–341. doi:10.1038/s41577-020-0321-6
  13. Vennema H, de Groot RJ, Harbour DA, et al. Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J Virol (1990) 64:1407-1409
  14. Lambert PH, Ambrosino DM, Andersen SR, et al. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines. Vaccine (2020) 38(31):4783-4791. doi:10.1016/j.vaccine.2020.05.064
  15. de Alwis R, Chen S, Gan S, et al. Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development. EbioMedicine (2020) 55:102768. doi:10.1016/j.ebiom.2020.102768
  16. Folegatti PM, Ewer KJ, Aley PK, et al. Safety and immunogenicity of the ChAdOx1 nCoV287 19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet (2020) 396:467–783. doi:10.1016/S0140-6736(20)31604-4
  17. Polack FP, Thomas SJ, Kitchin N. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med (2020) 383:2603–2615. doi:10.1056/NEJMoa2034577
  18. Ramasamy MN, Minassian AM, Ewer KJ, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet (2021) 396:1979–93. doi: 10.1016/S0140-6736(20)32466-1
  19. Chu L, McPhee R, Huang W, et al. mRNA-1273 Study Group. A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine. Vaccine (2021) S0264-410X(21)00153-5. doi:10.1016/j.vaccine.2021.02.007
  20. Liu L, Wei Q, Lin Q, et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight (2019) 4(4):e123158. doi:10.1172/jci.insight.123158.
  21. Ioannidis PA. Infection fatality rate of COVID-19 inferred from seroprevalence data. Bull WHO (2021) 99:19–33F. http://dx.doi.org/10.2471/BLT.20.265892
  22. Martines RB, Ritter JM, Matkovic E, et al. Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States Emerg Infect Dis (2020) 26:2005-2015. doi:10.3201/eid2609.202095
  23. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA (2020) 323:1239-1242. doi:10.1001/jama.2020.2648
  24. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respiratory Med (2020) 8:420-422 doi:10.1016/S2213-2600(20)30076-X
  25. Negro F. Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis? Swiss Medical Weekly (2020) 150:w20249. doi:10.4414/smw.2020.20249317
  26. Lei Y, Zhang J, Schiavon CR et al., Spike Protein Impairs Endothelial Function via Downregulation of ACE 2. Circulation Res (2021) 128:1323–1326. https://doi.org/10.1161/CIRCRESAHA.121.318902
  27. Lyons-Weiler J. Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity, J Translational Autoimmunity (2020) 3:100051. doi:10.1016/j.jtauto.2020.100051
  28. An H, Park J. Molecular Mimicry Map (3M) of SARS-CoV-2: Prediction of potentially immunopathogenic SARS-CoV-2 epitopes via a novel immunoinformatic approach. bioRxiv [Preprint]. 12 November 2020 [cited 2020 April 19] https://doi.org/10.1101/2020.11.12.344424
  29. Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med (2021). doi: 10.1056/NEJMoa2104840
  30. Othman M, Labelle A, Mazzetti I et al. Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance. Blood (2007) 109:2832–2839. doi:10.1182/blood-2006-06-032524
  31. Ortel TL. Acquired thrombotic risk factors in the critical care setting. Crit Care Med (2010) 38(2 Suppl):S43-50. doi:10.1097/CCM.0b013e3181c9ccc8
  32. Grubaugh ND, Petrone ME, Holmes EC. We shouldn’t worry when a virus mutates during disease outbreaks. Nat Microbiol (2020) 5:529–530. https://doi.org/10.1038/s41564-020-0690-4
  33. Greaney AJ, Starr TN, Gilchuk P, et al. Complete Mapping of Mutations to the SARS-CoV339 2 Spike Receptor-Binding Domain that Escape Antibody Recognition. Cell Host Microbe (2021) 29:44–57.e9. doi:10.1016/j.chom.2020.11.007.
  34. Lauring AS, Hodcroft EB. Genetic Variants of SARS-CoV-2—What Do They Mean? JAMA (2021) 325:529–531. doi:10.1001/jama.2020.27124
  35. Zhang L, Jackson CB, Mou H, et al. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv [Preprint]. June 12 2020 [cited 2021 Apr 19] https://doi.org/10.1101/2020.06.12.148726
  36. Korber B, Fischer WM, Gnanakaran S et al. Sheffield COVID-19 Genomics Group. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell (2020) 182:812-827.e19. doi:10.1016/j.cell.2020.06.043
  37. Francis T. On the doctrine of original antigenic sin. Proc Am Philos Soc (1960) 104:572–578.
  38. Vibroud C, Epstein SL. First flu is forever. Science (2016) 354:706–707. doi:10.1126/science.aak9816
  39. Weisblum Y, Schmidt F, Zhang F, et al. Escape from neutralizing antibodies by SARS354 CoV-2 spike protein variants. Elife (2020) 9:e61312. doi:10.7554/eLife.61312
 
Last edited:
In recent months, several NSFs collapsed and carried into SAF Medical Centers this year on stretchers, after third jab.

It is time for us to stop accusing "underlying conditions" and recognize the "underlying problems" and halt the senseless mRNA vaccination programme.

I challenge our God-damned policymakers to ask all SAF regulars to take the 4th mRNA jab and see them drop like flies.

Some NSFs were mocked for getting covid. There are now some sections that are completely covided.
With six weeks to NDP, we allocated reserve personnel for marching contingent, as some covid cases emerging among the participants.
 
Back
Top